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Background: Immunological theories suggest that changes in the 
immune system could prevent the ability to eliminate the endome-
trium of the pelvic cavity. In women with endometriosis is possible that 
changes in immunity mediated by T cells facilitate the implantation of 
endometrial fragments or cells in ectopic locations and recent studies 
have associated the FOXP3 gene with homeostasis of the immune 
system and the development of autoimmune diseases. We aimed to 
evaluate the expression of FOXP3 gene in both eutopic and ectopic 
endometrium of infertile women with endometriosis and controls. 
Methods: A case-control study was performed comprising 25 inferti-
le women with endometriosis and 44 fertile women without endome-
triosis. FOXP3 and GAPDH expression was measured by mRNA using 
quantitative reverse transcription polymerase chain reaction (qRT-PCR) 
based on TaqMan methodology. The Mann-Whitney test was used to 
compare the values between the groups.
Results: The results disclosed that mean expression of FOXP3 in 
eutopic endometrium of endometriosis group was significantly higher 
when compared to the control group (p=0,008), regardless the stage 
of the disease. Considering the samples of the ectopic endometrium, 
FOXP3 expression was also significantly higher in endometriosis group 
compared to the control group (p=0,004), regardless the stage of the 
disease. 
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Introduction
Endometriosis is a common gynecological disease, 
defined as the growth of endometrial tissue outside 
the uterine cavity that often results in dyspaure-
nia, dysmenorrhea, pelvic pain and infertility [1,2]. It 
affects 3-10% of women in their reproductive years 
and 20-50% of women with infertility [2,3].
Numerous hypotheses have been put forward to 
explain the presence of ectopic endometrial tissue 
and stroma. Immunological theories suggest that 
changes in the immune system could prevent the 
ability to eliminate the endometrium of the pelvic 
cavity [4,5]. In women with endometriosis is possi-
ble that changes in immunity mediated by T cells 
facilitate the implantation of endometrial fragments 
or cells in ectopic locations [6,7]. The immune cells 
which are likely to play roles in this destruction, 
including cells such as macrophages, natural killer 
[NK] and cytotoxic T-cells must be tightly regula-
ted in order to ensure that the immune response is 
specific to sloughed endometrial fragments and not 
the intact uterine tissue. The cells which are almost 
certainly the key regulators of this response are a 
distinct population of T-cells, known as regulatory 
T-cells, called Tregs [8,9].
Recent studies have associated the FOXP3 gene 
(Gene ID: 50943, Xp11.23) with homeostasis of the 
immune system and the development of autoimmu-
ne diseases [8,10,11]. The FOXP3 gene is primarily 
expressed in CD4+ CD25+ Tregs in normal physio-
logical conditions. It encodes FOXP3 protein which 
regulates the activation of T cell and functions as a 
transcriptional repressor and down-regulates cyto-
kine production in T cells [8,12-14].
The human endometrium is a tissue with high cell 
turnover and marked cyclical remodeling under the 
influence of ovarian steroid hormones. During the 
normal menstrual cycle the endometrium within the 
uterus is widely infiltrated by immune cells. The spe-
cific activities of these immune cells are crucial for 
the proper course of such reproductive processes as 
menstruation and implantation [15]. An alteration in 
Treg lymphocyte infiltration generally disrupts the 
immunological equilibrium [16]. The increase in the 
number of Treg cells depends upon estrogen levels, 
and estrogens are also responsible for the increase 
in the immune suppressive potential of these cells 
[17]. Estrogen levels generally seem to be linked 
with a decrease in TH1 response and the absence 
of Treg cell fluctuation can be linked to an immune 
defect arising with the development of endome-
triosis [16,18].
Considering the complex cellular and molecular 
mechanisms involved in endometriosis formation 
and progression, and that immune regulators are 
likely to play crucial roles in diseases within which 
numerous immune factors appear to be highly dis-
turbed, we aimed to verify a possible relationship 
between FOXP3 expression and the development/
progression of endometriosis.
Methods
The Subjects: Among the patients of the Human 
Reproduction and Genetics Center of the Faculdade 
de Medicina do ABC, Santo André, Brazil, 25 inferti-
le women with endometriosis (mean age 33.9±3.3y) 
were selected to take part in this study. They were 
Conclusion: The results of this study point to an association between 
the expression of FOXP3 and the genesis/progression of endometriosis
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diagnosed with endometriosis by laparoscopy and 
classified according to the American Society for 
Reproductive Medicine (19), with obligatory histo-
logical confirmation of the disease. Patients with 
acute or chronic disorders, especially autoimmune 
diseases, were excluded. In this group, minimal/mild 
(stage I and II) endometriosis was found in 15 cases 
(60.0%), and moderate/severe (stage III and IV) en-
dometriosis in 10 cases (40.0%).
Considering the characteristics of these patients 
such as mean age, duration of infertility, body mass 
index (Kg/m2), value of CA125 (miliUI/mL), value of 
FSH (miliUI/mL), LH (miliUI/mL), progesterone (ng/
mL), prolactin (ng/mL), presence of chronic pelvic 
pain, tubal obstruction and male factor infertility 
compared to the endometriosis stage are described 
in Table 1. The surgical indication for all patients was 
a complaint of infertility. 
Table 1: Characteristics of studied infertile patients with endometriosis.
Characteristics Minimal/Mild Moderate/Severe P-value
N 15 10
Age (Years) 33.4 (3.58) 34.44 (3.57) 0.090
Duration of Infertility (Years) 4.58 (3.84) 4.11 (3.25) 0.278
BMI (Kg/m2) 23.67 (2.26) 25.46 (3.26) 0.006
CA125 (miliUI/mL) 34.35 (32.98) 51.98 (36.86) <0.001
FSH (miliUI/mL) 6.03 (1.89) 6 (1.88) 0.478
LH (miliUI/mL) 6.69 (10.55) 5.06 (4.67) 0.088
Progesterone (ng/mL) 10.38 (6.73) 9.13 (10.18) 0.146
Prolactine (ng/mL) 16.49 (6.04) 16.37 (8.26) 0.456
Presence of Pevic Pain 10/15 (66%) 5/10 (50%) 0.680
Tubal Obstruction 4/15 (26%) 4/10 (40%) 0.791
Male Factor 2/15 (13%) 4/10 (40%) 0.292




Values expressed as mean (standard deviation).
A control group of 44 fertile women (mean age 
35.3 ± 4.6 y) was selected especially at the Family 
Planning Outpatient Clinic of the Faculdade de Me-
dicina do ABC among a group submitted to tubal 
ligation. In all of them, absence of endometriosis was 
confirmed by inspection of the pelvic cavity during 
the laparoscopy. None of these women had any per-
sonal and/or familial history of autoimmune diseases. 
Moreover, all women (cases and controls) had 
regular menstrual cycles (25-35 days) and did not 
use any hormone therapy for at least three months 
before surgery.
The investigation into the cause of infertility in-
cluded a hormonal and biochemical profile, testing 
for sexually transmitted diseases, imaging exami-
nations, investigation of genetic and/or immuno-
logical abnormalities, hysterosalpingography, hys-
teroscopy and laparoscopy, and semen analysis of 
the partner. Patients with endometriosis who did 
not achieve pregnancy, at least, after twelve na-
tural or induced cycles following laparoscopy were 
considered infertile.
Clinical data, peripheral blood and endometrial 
biopsies samples were collected only after explai-
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ning the objectives of the study and obtaining sig-
ned informed consent, as approved by the Faculda-
de de Medicina do ABC Research Ethics Committee 
(No.095/2009).
Biopsies: Samples were collected at the luteal 
phase of the menstrual cycle (21 ± 2 days). Euto-
pic endometrium samples were collected with the 
aspiration cannula (Pipelle®, Prodimed, France) and 
typical endometriotic lesions only of the peritoneum 
(ectopic endometrium) were collected during lapa-
roscopy/laparotomy. The fragments of the biopsies 
were immediately placed in an extender solution 
of RNA (RNA holder, BioAgency, Brazil) and subse-
quently stored in a freezer at -80°C.
RNA extraction: RNA extraction of endometrial 
biopsies and endometriotic lesions was carried 
out with Qiazol Lysis Reagent, according to the 
manufacturer’s instructions (Qiagen®, Turnberry 
Lane, CA, USA).
To measure the quantity and quality (purity) of 
RNA extracted, the extracted sample was measu-
red in NanoDrop 2000 spectrophotometer (Ther-
mo Scientific, CA/USA). The quality/purity of the 
material was measured by the ratio 230/260 and 
260/280.
cDNA synthesis: The cDNA synthesis was done 
from total RNA using the QuantiTect Reverse Trans-
cription Kit, according to the manufacturer’s ins-
tructions (Qiagen®, Valencia, California, United 
States).
FOXP3 gene expression: The expression of FOXP3 
(ID: 50943 - Hs01085834_m1) and GAPDH (ID 
2597-Hs99999905_m1) genes was measured by 
qRT-PCR, based on the TaqMan methodology using 
the equipment StepOne Real-Time PCR System (Life 
Technologies®, Foster City, CA, EUA).
PCR reactions were processed to a final volume 
of 25 μL, containing 12.5 μL of 2X TaqMan Uni-
versal PCR Master Mix (Life Technologies ®, Foster 
City, CA, USA), 1.25 μL TaqMan assay (20x), 1μl of 
sample cDNA, and 10.25 μL of RNAse-free water. 
The PCR conditions were those recommended by 
the manufacturer: initial denaturation at 50° C (2 
min) to initiate enzyme activity AmpErase UNG, 95 
°C (10 min) to initiate the activity of the enzyme 
AmpliTaq Gold DNA Polymerase, followed by 40 
cycles of denaturation at 95° C (15 sec) and annea-
ling/extension at 60 ° C (1 min).
The amount of FOXP3 mRNA from the control 
group was compared to the respective amounts 
of patients with endometriosis. The GAPDH gene 
was used as normalizer of the reactions. The results 
were analyzed by ΔΔCt method.(20)
Statistical analyses: Statistical analysis was perfor-
med using Stata 11.0. For comparison of quantitati-
ve variables such as age, duration of infertility, body 
mass index, value of CA125, amount of FSH, LH, 
progesterone and prolactin, t test was used, with 
results expressed as mean and standard deviation. 
To compare qualitative variables between groups 
such as the presence of chronic pelvic pain, presen-
ce of tubal and male factor infertility, compared to 
the staging of endometriosis, chi-square test was 
used.
The comparison between the values of FOXP3 
mRNA in the control group and the group of pa-
tients with endometriosis was performed using the 
Mann-Whitney. Due to non-normal distribution of 
the FOXP3 expression, we chose to describe the 
data by percentile values (25, 50 and 75) and the 
mean and confidence interval of 95%. A p-value 
<0.05 was considered statistically significant.
Results and Discussion
The average of FOXP3 expression found in both 
eutopic and ectopic endometrium of infertile wo-
men with endometriosis and controls were shown 
in Table 2. 
Considering the endometrium of the women stu-
died, the mean expression of FOXP3 was signifi-
cantly higher in the endometrium of endometriosis 
group than in control group (p=0.008), even when 
the expression of FOXP3 was analyzed in endome-
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Table 2:  Values of central tendency and dispersion of FOXP3 expression found in infertile women with 
endometriosis and controls.
Studied Group Eutopic Endometrium (n=25) Ectopic Endometrium (n=25)
FOXP3 expression 
P50 (P25 – P75) 
Mean (IC95%)
p* FOXP3 expression 
P50 (P25 – P75) 
Mean (IC95%)
p*
Endometriosis 0,54 (0,34 – 1,04) 2,57 (0,51 ; 4,64) 0,008 1,54 (1,03 – 2,77) 40,32 (-2,83 ; 83,47) 0,004
Minimal/Mild (n=15) 0,54 (0,34 – 1,04) 2,26 (0,25 ; 4,27) 0,007 1,71 (1,08 – 11,08)  42,11 (-13,92 ; 98,15) 0,003
Moderate/Severe (n=10) 0,46 (0,23 – 2,06) 3,05 (-1,80 ; 7,90) 0,002 1,29 (0,46 – 2,35) 37,62 (-44,56 ; 119,80) 0,007
Control Group (n=44) 0,99 (0,55 – 1,65) 1,48 (0,99 ; 1,98)  
P50, P25, P75: Percentile 50, 25 and 75. IC (95%): Confidence Interval of 95%.
* Compared to Control Group
triosis minimal/mild and moderate/severe separately. 
Regarding the samples of peritoneal endometrium 
(ectopic), FOXP3 expression was significantly hig-
her in endometriosis group compared to the con-
trol group (p=0.004), even when the expression of 
FOXP3 was analyzed in endometriosis minimal/mild 
and moderate/severe separately.
The Treg cells comprise two distinct populations: 
natural Tregs (nTreg), which originate in the thy-
mus and are specific to self-antigens presented by 
epithelial thymic cells, and induced Tregs, which are 
generated back into the periphery from T CD4+ 
(Tconv) cells through antigenic stimulation in the 
presence of TGFβ and foreign antigens [21]. Both 
populations of Treg lymphocytes express FOXP3, a 
transcription factor critical for homeostasis and the 
suppressor function of Tregs [10-12].
Considering the critical role of Treg cells in im-
pairing autoimmunity and previous results rela-
ting genetic polymorphisms in the FOXP3 gene to 
autoimmune diseases, we aimed to evaluate the 
FOXP3 expression in both eutopic and ectopic en-
dometrium of infertile women with endometriosis. 
The results disclosed that the mean expression of 
FOXP3 in the eutopic endometrium of endometrio-
sis group was significantly higher when compared 
to the control group, regardless the stage of the 
disease. Considering the samples of the ectopic 
endometrium, FOXP3 expression was significantly 
higher compared to the control group, especially 
in minimal/mild disease.
Berbic et al (2010) [9] showed that the density of 
peripheral FOXP3+ cells increases during the folli-
cular phase, reaching its peak during the late proli-
ferative phase, when serum estradiol levels are also 
elevated. It has been proposed that under normal 
conditions a pre-ovulatory rise in FOXP3+ cells may 
be required for the induction of immune tolerance 
required to facilitate successful embryo implanta-
tion, should it occur [15]. The failure to down-regu-
late FOXP3+ expression during the secretory phase 
in women with endometriosis may well be attribu-
ted to increased presence of endometrial antigens, 
as well as to continuous local estrogen production 
[22,23] both of which are probably stimulating con-
tinuous FOXP3+ cell proliferation in endometriosis.
In contrast, primary unexplained infertility has 
been associated with reduced expression of FOXP3 
mRNA in endometrial tissue in mid-secretory phase 
of the menstrual cycle [24], suggesting that impai-
red recruitment of Treg cells, or insufficient diffe-
rentiation of uterine T-cells into Treg cells even prior 
to conception may affect the capacity to establish 
pregnancy in women. 
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André et al (2011) [25] aimed to evaluate FOXP3 
polymorphisms (rs3761549, rs3761548, rs2232368, 
rs2232366 and rs2280883) in a group of infertile 
women with and without endometriosis and con-
trols. The single-marker analysis revealed that FOXP3 
rs3761549 was significantly associated with endo-
metriosis (p=0.003), regardless of the stage of the di-
sease. Considering the infertile group without endo-
metriosis, single-marker analysis revealed statistical 
difference for rs2280883 (p=0.024) and rs2232368 
(p=0.034) FOXP3 polymorphisms. No associations 
were found considering rs3761548 and rs2232366 
either for endometriosis-related infertility group or 
idiopathic infertility group. Haplotype analysis of 
five FOXP3 polymorphisms identified a haplotype 
‘‘CTTGA’’ associated with endometriosis (p=0.011) 
and also identified a haplotype “ACTAG” that was 
associated with idiopathic infertility (p=0.014). After 
Bonferroni correction, only the rs3761549 polymor-
phism associated with endometriosis remains statis-
tically significant, strengthening the association of 
this polymorphism with the disease. The authors 
concluded that FOXP3 polymorphisms can be asso-
ciated with risk of idiopathic infertility (rs2280883 
and rs2232368) and endometriosis (rs3761549) in 
Brazilian women.
Moreover, recently our group [26] demonstra-
ted a cumulative effect of two genetic polymor-
phisms (FOXP3 C-2383T/rs3761549 and FCRL3 C-
169T/rs7528684) those were previously shown to 
be associated with endometriosis. The combined 
genotypes of FCRL3 and FOXP3 polymorphisms 
showed a positive association between genoty-
pes FCRL3TT/FOXP3CT, FCRL3CT/FOXP3CT and 
FCRL3CC/FOXP3CT and the risk of endometriosis 
development. Besides, a progression of the disea-
se risk was observed according to the presence of 
one or two copies of risk allele FCRL3 C and only 
one copy of risk allele FOXP3 T (OR=2.14, OR=3.25 
and OR=6.0, respectively, for genotypes FCRL3TT/
FOXP3CT, FCRL3CT/FOXP3CT and FCRL3CC/
FOXP3CT), suggesting a possible gene-gene inte-
raction leading to a cumulative effect on endome-
triosis development.
Utilizing the induced non-human primate (Papio 
anubis) model of endometriosis, Braundmeier et 
al (2012) [27] showed that, in control animals, the 
proportion of peripheral natural Tregs (nTregs) was 
reduced (P<0.05) during the mid- and late secre-
tory stages of the menstrual cycle compared with 
menses. The induction of disease decreased peri-
pheral Treg expression at early time points (P<0.05) 
and this remained low throughout the time course, 
compared with the pre-inoculatory level of an indi-
vidual. FOXP3 gene expression and Treg populations 
were also decreased in the eutopic endometrium 
(P<0.05) compared with control animals, whereas 
these parameters were increased in ectopic lesions 
(P<0.05), compared with the eutopic endometrium, 
suggesting that a reduction in peripheral Tregs may 
be a causative factor for endometriosis-associated 
infertility, while the increase in ectopic Treg expres-
sion may aid lesion development. Furthermore, en-
dometriosis appears to disrupt Treg recruitment in 
both eutopic and ectopic endometrium. As Braund-
meier et al (2012) [27], we found that, in human, 
FOXP3 is aberrant expressed in both eutopic and 
ectopic endometrium of infertile women with endo-
metriosis, strengthening the association of FOXP3 
and the genesis/progression of endometriosis.
Chen et al (2012) [28] aimed to investigate the 
pathogenesis of infertility in women with endome-
triosis by comparing FoxP3+ T regulatory cells expres-
sion in the eutopic endometrium of infertile women 
with endometriosis (n=27) and endometrium from 
healthy fertile women (n=20) in peri-implantation 
phase by quantitative real-time RT-PCR and FoxP3 
protein expression was assessed by immunohisto-
chemistry. Similarly with our findings they observed 
that FoxP3 mRNA expression in all infertile patients 
with endometriosis was significantly higher than the 
control group. Further analysis based on the extent 
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of the disease revealed that FoxP3 mRNA expression 
in infertile patients with advanced endometriosis 
was significantly higher than the mild endometriosis 
group and the control group. Immunohistochemis-
try analysis showed predominant positive staining 
for FoxP3 protein in the endometrial stroma. 
Podgaec et al [29] also in 2012 evaluated 
CD4+CD25highFoxp3+ cells and IL-6, IL-10, IL-17, 
and TGFb in the peritoneal fluid of women with 
endometriosis (n=70) and controls (n=28) using flow 
cytometry abd RT-PCR. The results disclosed that 
the lymphocytes in the peritoneal fluid of women 
with endometriosis were higher CD4+CD25high 
compared to the control group. Foxp3 expression 
was similarly elevated in patients with the disease 
compared to those without. IL-6 and TGF-b were 
also higher in endometriosis group and   IL-10 and 
IL-17 showed no significant differences between 
the two groups. The authors concluded that pe-
ritoneal fluid of patients with endometriosis had a 
higher percentage of CD4+CD25highFoxp3+ cells 
and also higher levels of IL-6 and TGF-b compa-
red to women without the disease, suggesting that 
CD4+CD25highFoxp3+ cells may play a role in the 
pathogenesis of endometriosis.
Since retrograde menstruation is a common 
phenomenon that occurs in the majority of wo-
men during their reproductive life, this fact alone 
is not likely to be responsible for the onset of en-
dometriosis. It is believed that intrinsic properties 
of the endometrial tissue are responsible for en-
suring viability, adhesion, neovascularization and 
establishment of ectopic lesions in women with 
endometriosis [30].
Endometriosis has been widely characterized as 
an inflammatory disease. Numerous studies have 
shown that peritoneal leukocytes and their inflam-
matory mediators exert local effects, creating a mi-
croenvironment that may facilitate the development 
and progression of these lesions. The immune sys-
tem appears to be significantly deregulated not only 
at the injury site, but also in the uterine cavity of 
women with endometriosis [4,30].
Conclusion
It is important to point out that Tregs are respon-
sible for both beneficial and deleterious effects. 
Although Tregs prevent excessive inflammatory and 
autoimmune responses, they also suppress neces-
sary immunity and, therefore, also need regulations 
to restrict their effects.
In conclusion, our data point to an association 
between the expression of FOXP3 and the genesis/
progression of endometriosis.
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